BREAKING: The FDA just made it official. Advisory committee meetings are now scheduled for July 23 24 to review reclassifying peptides back to legal compounding status. Here's what's happening: After the BPC 157 Benefits, Dosage & Before After Results BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with The Science Behind Our BPC 157 Peptide